FOXD2 and central nervous system cancer: For example, Xia et al. confirmed that FER1L4 adjusts the cycle and proliferation of glioma cells [9], Ni et al. proposed that FoxD2-AS1 adjusts the PI3K/AKT signaling pathway as well as the miR-185-5P/HMGA2 axis, so as to accelerate the progression of glioma [10], and Yang et al. found that lncRNA HERC2P2 is a tumor suppressor in glioma [11].